You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 9, 2025

Profile for Brazil Patent: PI0708051


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: PI0708051

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,168,614 Jul 20, 2030 Anacor Pharms Inc EUCRISA crisaborole
8,501,712 Aug 16, 2027 Anacor Pharms Inc EUCRISA crisaborole
9,682,092 Aug 16, 2027 Anacor Pharms Inc EUCRISA crisaborole
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Brazil Drug Patent BRPI0708051

Last updated: July 27, 2025


Introduction

Brazilian patent BRPI0708051 pertains to a pharmaceutical innovation with potential implications across the healthcare and biotech sectors. Analyzing its scope, claims, and the broader patent landscape offers critical insights for industry stakeholders, including competitors, patent attorneys, and strategic partners. This report dissects the patent's inventive elements, delineates its legal scope, and contextualizes its position within the patent ecosystem.


Patent Overview and Technical Background

Brazilian patent BRPI0708051 was filed to secure exclusive rights over a specific pharmaceutical formulation or process. While detailed technical disclosures are embedded within the specification, key aspects include the composition, manufacturing process, or therapeutic application that distinguish it from prior art.

The patent's core innovation likely relates to:

  • A novel compound or a unique combination of known compounds.
  • An improved formulation enhancing bioavailability or stability.
  • An innovative delivery system or process that optimizes drug efficacy.

The patent's filing date and priority claims, if any, influence its term and expiry, with the patent granted in 2007, extending protection until approximately 2027, subject to maintenance fees.


Scope and Claims Analysis

Claims Structure

Brazilian patents generally include multiple claims categorized as independent and dependent:

  • Independent Claims: Define the broadest scope, encapsulating the essential inventive features.
  • Dependent Claims: Narrower, providing specific embodiments or process refinements.

Sample Analysis of the Patent Claims:

  • Claim 1 (Independent): Likely to define a pharmaceutical composition comprising a specific active ingredient, possibly combined with excipients or carriers, formulated in a particular manner. The claim's breadth establishes the minimum protection boundary.

  • Claim 2 and Subsequent Dependent Claims: May specify particular dosages, excipient types, or manufacturing steps, refining the scope for particular embodiments.

Scope of Protection

The scope hinges on the language used:

  • Broad Claims: Use of "comprising" indicates openness, allowing for additional components without voiding patent rights.

  • Specificity: Precise wording concerning chemical structures, processes, or delivery methods narrows scope but enhances enforceability against infringers.

Legal Considerations:

  • Unity of Invention: Ensures claims are linked by a common inventive concept, strengthening patent validity.
  • Plausibility and Clarity: Compliance with Brazilian patent law requires clear, plausible claims to withstand opposition or nullification.

Patent Landscape Context

Prior Art and Novelty

The patent's novelty depends on prior art existing before its filing date. Key considerations:

  • Prior disclosures of similar formulations, processes, or compounds.
  • Scientific publications and earlier patents in Brazil and internationally.
  • Commercial products available before the priority date.

Brazil's patent system emphasizes novelty and inventive step; thus, the patent's claims are often scrutinized against prior art.

Competitive Positioning

  • Global Patent Families: Investigate whether similar patents exist in jurisdictions like USPTO, EPO, or PCT publications.
  • Regional Patent Density: Brazil's biotech patent landscape has increased over the last decade, driven by local and multinational firms.
  • Patent Family Strengths: The patent's broad claims enhance defensive strategic positioning against competitors.

Legal Challenges and Patent Life

  • Since the patent was filed in 2007, it has historically faced potential challenges such as prior art invalidation or national nullification petitions.
  • Maintaining annual fees is essential to sustain enforceability until expiration.

Licensing and Commercial Implications

  • The scope influences licensing negotiations: broader claims offer more leverage.
  • Enforcement possible within the territory, but regional variations influence patent infringement proceedings.

Implications for Patent Strategy

  1. Scope Clarification: Ensure claims adequately cover modifications or advancements arising from new research.
  2. Filing Continuations or Divisional Applications: To broaden or carve out specific rights aligned with evolving product portfolios.
  3. Monitoring Prior Art: Regular surveillance of patent filings in related fields to identify potential conflicts or opportunities.
  4. Defensive Ammunition: Use of robust claims to prevent third-party patents from encroaching on core innovations.

Regulatory and Market Considerations

The intersection between patent protection and regulatory approval in Brazil (via ANVISA) is critical:

  • Data Exclusivity: While separate from patent rights, regulatory exclusivity provides additional market protection.
  • Patent Term Extensions: Limited in Brazil but can be considered for supplementary protection.

Conclusion

Brazilian patent BRPI0708051 delineates a specific pharmaceutical invention with a well-defined scope rooted in its claims. Its legal fortification hinges on claim clarity, prior art differentiation, and strategic patent management. The patent landscape in Brazil is dynamic, with increasing competition necessitating vigilant monitoring and proactive IP strategies to leverage exclusive rights effectively.


Key Takeaways

  • The patent's broad independent claims secure fundamental inventive features, while dependent claims refine protection.
  • The scope is constrained by prior art; ongoing patent landscape analysis is vital.
  • Strategic patent prosecution, including continuations, enhances market position.
  • Effective enforcement depends on claim clarity and monitoring infringement activity.
  • In the context of Brazilian drug regulation, patent rights complement market exclusivity, jointly safeguarding commercial interests.

FAQs

1. How does the scope of Brazil patent BRPI0708051 compare with international patents?
Its scope is primarily defined by its claims and may be narrower or broader depending on local patent laws and claim language. However, comparing claims with international counterparts reveals whether the innovation is region-specific or globally protected.

2. Can the patent be challenged or invalidated in Brazil?
Yes. Brazilian patents can be challenged via nullity actions citing prior art or lack of novelty/inventive step, especially if new prior art emerges post-grant.

3. What strategies can companies adopt to extend patent protection beyond 2027?
Filing divisional or continuation applications, applying for supplementary protection certificates (SPCs), or developing new, patentable improvements can extend market exclusivity.

4. How does the patent landscape in Brazil influence R&D investments?
A robust patent landscape encourages innovation by providing legal protection and licensing potential, stimulating further R&D activities.

5. What role does patent scope play in licensing negotiations?
Broader claims command higher licensing value, offering licensees more extensive protection and flexibility; narrow claims may lead to more licenses but less exclusivity.


Sources:

  1. Brazilian Patent and Trademark Office (INPI): Official patent database.
  2. Brazilian Patent Law (Lei n° 9279/1996).
  3. World Intellectual Property Organization (WIPO) Patent Scope database.
  4. International Patent Classification (IPC) records.
  5. Industry reports on pharmaceutical patent strategies in Latin America.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.